Sterling Capital Management LLC Sells 4,146 Shares of Humana Inc. (NYSE:HUM)

Sterling Capital Management LLC trimmed its holdings in Humana Inc. (NYSE:HUM - Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 39,020 shares of the insurance provider's stock after selling 4,146 shares during the period. Sterling Capital Management LLC's holdings in Humana were worth $9,900,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in HUM. HighTower Advisors LLC lifted its position in Humana by 2.1% during the third quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider's stock worth $2,852,000 after acquiring an additional 187 shares during the last quarter. MML Investors Services LLC lifted its holdings in Humana by 15.6% during the 3rd quarter. MML Investors Services LLC now owns 4,737 shares of the insurance provider's stock worth $1,500,000 after purchasing an additional 638 shares during the last quarter. LRI Investments LLC boosted its stake in Humana by 1,021.4% in the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock valued at $50,000 after purchasing an additional 143 shares during the period. Coldstream Capital Management Inc. grew its holdings in Humana by 27.3% in the 3rd quarter. Coldstream Capital Management Inc. now owns 3,318 shares of the insurance provider's stock valued at $1,032,000 after buying an additional 712 shares in the last quarter. Finally, Toronto Dominion Bank increased its position in Humana by 1.3% during the 3rd quarter. Toronto Dominion Bank now owns 59,992 shares of the insurance provider's stock worth $19,002,000 after buying an additional 754 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Remove Ads

Humana Price Performance

HUM stock traded down $3.09 during midday trading on Wednesday, reaching $283.69. 475,876 shares of the stock were exchanged, compared to its average volume of 1,746,125. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $34.24 billion, a PE ratio of 28.51, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a fifty day moving average price of $265.57 and a 200 day moving average price of $270.22.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on HUM. Mizuho upped their price target on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Barclays increased their price target on Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research report on Friday, April 11th. Morgan Stanley dropped their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. Finally, Robert W. Baird increased their target price on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Humana presently has an average rating of "Hold" and an average price target of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.